Chinese Journal of Pharmacovigilance ›› 2026, Vol. 23 ›› Issue (8): 867-874.
DOI: 10.19803/j.1672-8629.20260240

Previous Articles     Next Articles

HPLC fingerprint for Jiuwei Qianghuo pills and quality evaluation

Liu Jingjing1, Liu Shusen2, Li Siqi2, Xu Beilei2#, Liu Jing1,*   

  1. 1Institute for Control of Chinese Traditional Medicine and Ethnic Medicine, National Institutes for Food and Drug Control, Beijing 100050, China;
    2School of Pharmacy, Harbin University of Commerce, Harbin Heilongjiang 150076, China
  • Received:2026-03-25 Online:2026-08-15 Published:2026-08-17

Abstract: Objective To analyze the potential index components of Jiuwei Qianghuo pills and investigate inter-manufacturer quality differences in order to provide a reference for quality evaluation. Methods The HPLC fingerprint of Jiuwei Qianghuo pills was established, and similarity was calculated using the similarity evaluation system for chromatographic fingerprints of traditional Chinese medicine. Common peaks were identified by HPLC-MS via comparisons with reference substances and literature retrieval while their botanical origins were traced by comparing single medicinal materials with the whole formulation. Network pharmacology was employed to construct a component-target network and perform pathway enrichment analysis to identify key components. Results A total of 18 common peaks were identified in the fingerprint and attributed to their respective medicinal sources: peaks 1, 17, and 18 to Atractylodis Rhizoma, peaks 2, 5, and 7 to Saposhnikoviae Radix, peaks 3, 8, and 14 to Notopterygii Rhizoma et Radix, peaks 6, 9, 10, and 11 to Scutellariae Radix, peaks 13 and 16 to Angelicae Dahuricae Radix, peak 4 to Rehmanniae Radix, peak 12 to Glycyrrhizae Radix et Rhizoma, and peak 15 to Chuanxiong Rhizoma. The similarity of fingerprints for 8 batches of samples ranged from 0.883 to 0.971, indicating considerable quality variations between manufacturers. A total of 632 intersection targets were obtained between components and diseases, with the pills primarily acting against wind chill or common colds through the PI3K-Akt signaling pathway, the MAPK signaling pathway, among others. Five key targets and seven key active components were identified, suggesting that the therapeutic effects of Jiuwei Qianghuo pills were mediated through multiple components, targets, and pathways. Conclusion The established HPLC fingerprint is stable and reliable. Combined with network pharmacology to predict potential active ingredients, targets, and pathways, this study provides a reference for elucidating the pharmacodynamic material basis and quality control of Jiuwei Qianghuo pills.

Key words: Jiuwei Qianghuo Pills, HPLC Fingerprint Spectrum, HPLC-MS, Similarity Analysis, Quality Evaluation, Network Pharmacology

CLC Number: